Aquestive Therapeutics promotes Cassie Jung to COO effective June 3, 2024

Aquestive Therapeutics, Inc.

Cassie Jung, 45, promoted to Chief Operating Officer, effective June 3, 2024.
Jung joined Aquestive in 2004 and served as VP Operations since 2019.
Annual base salary increased to $349,800; target incentive at least 40% of base.
No family relationships with directors/officers or reportable transactions.
Employment agreement will be filed with next 10-Q.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Cassie Jung

Chief Operating Officer

AQST · Aquestive Therapeutics, Inc.

Effective: 2024-06-03
Filed: June 6, 2024, 7:59 PM ET

Aquestive Therapeutics, Inc. (the “Company”) has promoted Cassie Jung, 45, to Chief Operating Officer, effective June 3, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cassie Jung changed role as Chief Operating Officer at Aquestive Therapeutics, Inc..

Action: promoted
Role: Chief Operating Officer

Exact text from the filing

Aquestive Therapeutics, Inc. (the “Company”) has promoted Cassie Jung, 45, to Chief Operating Officer, effective June 3, 2024.

View on SEC.gov

Aquestive Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-027028

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.